Shares of Health Care sector company Merck & moved 6.4% today, and are now trading at a price of $83.64. The Large-Cap stock's daily volume was 14,338,330 compared to its average volume of 12,348,944. The S&P 500 index returned a 0.0% performance.
Merck & Co., Inc. operates as a healthcare company worldwide. The company is based in Rahway and has 73,000 full time employees. Its market capitalization is $208,927,080,448. Merck & currently offers its equity investors a dividend that yields 4.0% per year.
25 analysts are following Merck & and have set target prices ranging from $82.0 to $141.0 per share. On average, they have given the company a rating of buy. At today's prices, MRK is trading -17.67% away from its average analyst target price of $101.6 per share.
Over the last year, MRK shares have gone down by -31.5%, which represents a difference of -48.2% when compared to the S&P 500. The stock's 52 week high is $114.79 per share and its 52 week low is $73.31. With average free cash flows of $14.08 Billion that have been growing at an average rate of 12.4% over the last 5 years, Merck & declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 21,468,000 | 3,372,000 | 18,096,000 | -33.2 |
| 2023 | 13,006,000 | 14,083,000 | 27,089,000 | 84.19 |
| 2022 | 19,095,000 | 4,388,000 | 14,707,000 | 69.55 |
| 2021 | 13,122,000 | 4,448,000 | 8,674,000 | 48.94 |
| 2020 | 10,253,000 | 4,429,000 | 5,824,000 | -42.17 |
| 2019 | 13,440,000 | 3,369,000 | 10,071,000 |
